Astrocytic adenosine A 2A receptors control the amyloid-β peptide-induced decrease of glutamate uptake

M Matos, E Augusto, NJ Machado… - Journal of …, 2012 - content.iospress.com
Alzheimer's disease (AD) is characterized by a progressive cognitive impairment tightly
correlated with the accumulation of amyloid-β (Aβ) peptides (mainly Aβ 1-42). There is a …

Astrocytic adenosine A2A receptors control the amyloid-β peptide-induced decrease of glutamate uptake.

M Matos, E Augusto, NJ Machado… - Journal of Alzheimer's …, 2012 - europepmc.org
Alzheimer's disease (AD) is characterized by a progressive cognitive impairment tightly
correlated with the accumulation of amyloid-β (Aβ) peptides (mainly Aβ (1-42)). There is a …

Astrocytic adenosine A2A receptors control the amyloid-β peptide-induced decrease of glutamate uptake

M Matos, E Augusto, NJ Machado… - Journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is characterized by a progressive cognitive impairment tightly
correlated with the accumulation of amyloid-β (Aβ) peptides (mainly Aβ (1-42)). There is a …

[PDF][PDF] Astrocytic Adenosine A2A Receptors Control the Amyloid-ß Peptide-Induced Decrease of Glutamate Uptake

M Matos, E Augusto, NJ Machado… - Journal of Alzheimer's …, 2012 - academia.edu
Alzheimer's disease (AD) is characterized by a progressive cognitive impairment tightly
correlated with the accumulation of amyloid-ß (Aß) peptides (mainly Aß1-42). There is a …

[PDF][PDF] Astrocytic Adenosine A2A Receptors Control the Amyloid-ß Peptide-Induced Decrease of Glutamate Uptake

M Matosa, E Augustoa, NJ Machadoa… - Journal of Alzheimer's …, 2012 - researchgate.net
Alzheimer's disease (AD) is characterized by a progressive cognitive impairment tightly
correlated with the accumulation of amyloid-ß (Aß) peptides (mainly Aß1-42). There is a …

[PDF][PDF] Astrocytic Adenosine A2A Receptors Control the Amyloid-ß Peptide-Induced Decrease of Glutamate Uptake

M Matosa, E Augustoa, NJ Machadoa… - Journal of Alzheimer's …, 2012 - academia.edu
Alzheimer's disease (AD) is characterized by a progressive cognitive impairment tightly
correlated with the accumulation of amyloid-ß (Aß) peptides (mainly Aß1-42). There is a …